Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Baylor University Medical Center, Charles A Sammons Cancer Center, Dallas, Texas, United States
Contact: Study coordinator (Solid Tumor Team) · corcsolidtumor@bswhealth.org

Study leads

A. Scott Paulson, MD
Principal Investigator
Charles A. Sammons Cancer Center/Texas Oncology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Metastatic Pancreatic Adenocarcinoma · Stage IV Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Columbus, United States

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Pancreatic Adenocarcinoma Locally Advanced

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

Resectable Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Kaohsiung City, Taiwan · Kaohsiung City, Taiwan